
Dapaquest M 10mg/1000mg Tablet ER
Marketer
Morepen Laboratories Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (1000mg)
Overview Dapaquest M 10mg/1000mg Tablet ER
Dapaquest M 10mg/1000mg Extended-Release tablets combine two medications to manage type 2 diabetes. This dual-action therapy effectively lowers elevated blood glucose, minimizing the risk of severe diabetic complications, including cardiovascular disease. Dapaquest M can be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician and should never be altered without their guidance; discontinuation may lead to dangerously elevated blood sugar, potentially causing kidney failure or vision loss. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and appropriate weight management as directed by your doctor. Commonly reported side effects include throat irritation, nasal stuffiness, rhinorrhea, headache, nausea, emesis, and diarrhea. Adequate hydration is crucial to prevent dehydration. Genital fungal infections are a potential side effect; diligent hygiene practices can help mitigate this risk. Prior to commencing treatment, disclose any kidney or liver dysfunction, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical counsel before initiating therapy. Limit alcohol consumption while taking Dapaquest M to lessen the likelihood of adverse effects. Regular blood glucose monitoring is essential throughout treatment.
Uses of Dapaquest M 10mg/1000mg Tablet ER
Managing Type 2 Diabetes
Major Benefits of Dapaquest M 10mg/1000mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Dapaquest M 10mg/1000mg Extended-Release tablets with food.
Common Side effects of Dapaquest M 10mg/1000mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dapaquest M 10mg/1000mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Dapaquest M 10mg/1000mg Extended-Release Tablet with food.
How Dapaquest M 10mg/1000mg Tablet ER works:
Dapagliflozin and Metformin, combined as Dapaquest M 10mg/1000mg Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual action leads to superior glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapaquest M 10mg/1000mg Tablet ER with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Dapaquest M 10mg/1000mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dapaquest M 10mg/1000mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Dapaquest M 10mg/1000mg Extended-Release tablets. Dosage modification of Dapaquest M 10mg/1000mg Extended-Release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Dapaquest M 10mg/1000mg Extended-Release tablets cautiously. Dosage modification of Dapaquest M 10mg/1000mg Extended-Release tablets might be necessary. Physician consultation is recommended.
What if you forget to take Dapaquest M 10mg/1000mg Tablet ER :
Should you forget a Dapaquest M 10mg/1000mg Extended-Release tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapaquest M 10mg/1000mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
